| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
20,067 |
17,981 |
$1.44M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
11,971 |
10,262 |
$1.38M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
2,671 |
2,227 |
$344K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
305 |
270 |
$195K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
24,687 |
19,908 |
$122K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,719 |
1,578 |
$89K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
2,007 |
1,561 |
$88K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
6,124 |
5,035 |
$88K |
| G0378 |
Hospital observation service, per hour |
1,303 |
1,015 |
$83K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
14,672 |
11,463 |
$73K |
| 80050 |
General health panel |
1,632 |
1,479 |
$65K |
| 80053 |
Comprehensive metabolic panel |
7,967 |
7,077 |
$65K |
| 80061 |
Lipid panel |
6,154 |
5,585 |
$64K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,315 |
1,971 |
$54K |
| 94762 |
|
1,911 |
1,511 |
$41K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
505 |
385 |
$39K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
807 |
731 |
$29K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,427 |
1,035 |
$27K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,008 |
818 |
$24K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
79 |
69 |
$21K |
| 36415 |
Collection of venous blood by venipuncture |
13,271 |
9,832 |
$19K |
| 70450 |
Computed tomography, head or brain; without contrast material |
59 |
49 |
$18K |
| 71045 |
Radiologic examination, chest; single view |
1,658 |
1,365 |
$17K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
127 |
119 |
$16K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,444 |
1,251 |
$16K |
| 71046 |
Radiologic examination, chest; 2 views |
346 |
307 |
$15K |
| 87276 |
|
1,578 |
834 |
$15K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,293 |
1,082 |
$15K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,984 |
1,797 |
$14K |
| 81025 |
|
1,857 |
1,660 |
$13K |
| 81003 |
|
9,636 |
8,092 |
$12K |
| 87275 |
|
842 |
747 |
$10K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
719 |
448 |
$10K |
| 93041 |
|
689 |
572 |
$8K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
589 |
525 |
$7K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
34 |
24 |
$6K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
413 |
357 |
$5K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
516 |
323 |
$5K |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
26 |
13 |
$3K |
| 87070 |
|
441 |
384 |
$3K |
| 87430 |
|
212 |
194 |
$3K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
159 |
117 |
$3K |
| 82552 |
|
344 |
251 |
$3K |
| 86140 |
|
447 |
394 |
$2K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
95 |
85 |
$2K |
| 87110 |
|
111 |
96 |
$2K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
80 |
67 |
$2K |
| 84484 |
|
260 |
183 |
$2K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,470 |
1,222 |
$1K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
21 |
21 |
$1K |
| 84443 |
Thyroid stimulating hormone (TSH) |
113 |
100 |
$1K |
| 94664 |
|
38 |
27 |
$1K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
131 |
52 |
$1K |
| 72050 |
|
13 |
12 |
$1K |
| J2704 |
Injection, propofol, 10 mg |
1,812 |
1,450 |
$1K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
222 |
194 |
$1K |
| 80076 |
|
215 |
182 |
$1K |
| 85652 |
|
455 |
402 |
$975.27 |
| C1751 |
Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) |
295 |
235 |
$956.74 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,454 |
1,224 |
$865.58 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
16 |
12 |
$825.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
33 |
15 |
$821.35 |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
17 |
15 |
$532.86 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
46 |
42 |
$486.50 |
| 84134 |
|
83 |
74 |
$447.03 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
13 |
13 |
$424.59 |
| 82150 |
|
89 |
70 |
$351.22 |
| 82607 |
|
28 |
26 |
$349.41 |
| 82746 |
|
29 |
27 |
$340.60 |
| 82043 |
|
76 |
71 |
$317.32 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
108 |
88 |
$225.58 |
| 99406 |
|
17 |
13 |
$221.52 |
| 94760 |
|
59 |
25 |
$210.25 |
| 87899 |
|
16 |
15 |
$208.91 |
| J3490 |
Unclassified drugs |
80 |
48 |
$191.30 |
| 84439 |
|
18 |
15 |
$135.30 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
28 |
25 |
$107.82 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
147 |
117 |
$82.21 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
203 |
180 |
$76.24 |
| 83735 |
|
14 |
12 |
$75.73 |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
154 |
127 |
$57.43 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
31 |
26 |
$55.69 |
| 85651 |
|
15 |
14 |
$55.22 |
| 83880 |
|
15 |
12 |
$39.26 |
| 36000 |
|
15 |
13 |
$29.56 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
72 |
51 |
$24.76 |
| 86901 |
|
24 |
23 |
$0.00 |